{"protocolSection":{"identificationModule":{"nctId":"NCT06482138","orgStudyIdInfo":{"id":"S67380"},"organization":{"fullName":"Universitaire Ziekenhuizen KU Leuven","class":"OTHER"},"briefTitle":"Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation","officialTitle":"Dysfunction of Olfaction After SARS-CoV-2 Infection: Morphological and Histomolecular Investigation of Olfactory Cleft Biopsies and Cytobrushes","acronym":"DysOSMIC"},"statusModule":{"statusVerifiedDate":"2024-02","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-01-24","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-12-31","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-03-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-02-19","studyFirstSubmitQcDate":"2024-06-28","studyFirstPostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"},"lastUpdateSubmitDate":"2024-06-28","lastUpdatePostDateStruct":{"date":"2024-07-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Universitaire Ziekenhuizen KU Leuven","class":"OTHER"},"collaborators":[{"name":"University Hospital, Geneva","class":"OTHER"},{"name":"Max Planck Research Unit for Neurogenetics","class":"UNKNOWN"},{"name":"University Hospital Carl Gustav Carus","class":"OTHER"},{"name":"University of Zurich","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Investigation of the mechanisms of persistent SARS-CoV-2 associated olfactory dysfunction (OD) in patients with well-documented olfactory function. The investigators plan to collect olfactory cleft biopsies and cytobrushes in COVID-19 patients and controls.","detailedDescription":"An explorative prospective clinical study using human body materials of living post-COVID-19 patients with and without OD, to study the mechanisms of persisting olfactory dysfunction. Patients consult ENT specialist for medical purposes and undergo standard-of-care diagnostics and management. The collected tissues from the olfactory cleft mucosa will be analyzed using single cell RNA sequencing and RNAscope combined with immunohistochemistry."},"conditionsModule":{"conditions":["Covid19","Olfactory Dysfunction"],"keywords":["Olfactory Dysfunction","COVID-19","SARS-CoV-2","Anosmia","Hyposmia"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NON_RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"BASIC_SCIENCE","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":160,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Control","type":"OTHER","description":"Biopsy and cytobrush during a scheduled structural intervention in general anesthesia","interventionNames":["Procedure: Biopsy and Cytobrush"]},{"label":"Olfactory Dysfunction","type":"OTHER","description":"Biopsy and cytobrush during consultation in local anesthesia","interventionNames":["Procedure: Biopsy and Cytobrush"]}],"interventions":[{"type":"PROCEDURE","name":"Biopsy and Cytobrush","description":"Collection of olfactory cleft biopsies and cytobrushes","armGroupLabels":["Control","Olfactory Dysfunction"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Analysis of olfactory cleft biopsies","description":"Morphological and histomolecular differences between OD and control patients\n\n* Evaluating tissue pathology:\n\n  * Metaplasia\n  * hypertrophy\n  * aberrant scar formation\n  * apoptosis\n  * presence of inflammatory cells \\[H\\&E, CD68 and CD3 stainings, RNAscope\\]\n* Presence of SARS-CoV-2 RNA\n* Percentage of OSNs versus sustentacular cells; maturation of OSNs","timeFrame":"From enrollment of 1 patient until analyzed, 1 month"},{"measure":"Analysis of olfactory cytobrushes","description":"Morphological and histomolecular differences between OD and control patients\n\n* Evaluating tissue pathology:\n\n  * Metaplasia\n  * hypertrophy\n  * aberrant scar formation\n  * apoptosis\n  * presence of inflammatory cells \\[H\\&E, CD68 and CD3 stainings, RNAscope\\]\n* Presence of SARS-CoV-2 RNA\n* In the olfactory epithelium: percentage of OSNs versus sustentacular cells; maturation of OSNs","timeFrame":"From enrollment of 1 patient until analyzed, 1 month"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Olfactory Dysfunction group: Presence of evident OD (Parosmia, Threshold-Discrimination-Identification (TDI)-score ≤24, Subjective abnormal quantitative olfactory function; measured by a visual analogue score (VAS) of smell impairment ≥5/10\n* Control group: No OD (TDI-score \\&gt;30.5.)\n\nExclusion Criteria:\n\n* Presence of concomitant nasal mucosal pathology that might affect olfactory function or bias the study investigations\n* Use of anticoagulation therapy\n* Allergy to local anesthetics","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Laura van Gerven","role":"CONTACT","phone":"+3216336342","email":"laura.vangerven@uzleuven.be"},{"name":"Sabrina Bischoff","role":"CONTACT","phone":"+41763655671","email":"sabrina.bischoff@uzleuven.be"}],"overallOfficials":[{"name":"Laura van Gerven","affiliation":"UZ/KU Leuven","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"UZ/KU Leuven","status":"RECRUITING","city":"Leuven","state":"Vlaams-Brabant","zip":"3000","country":"Belgium","contacts":[{"name":"Laura van Gerven","role":"CONTACT","phone":"+3216336342","email":"laura.vangerven@uzleuven.be"},{"name":"Laura van Gerven","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Sabrina Bischoff","role":"SUB_INVESTIGATOR"},{"name":"Marnick Clijsters","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":50.87959,"lon":4.70093}},{"facility":"Max Planck Research Unit for Neurogenetics","status":"ACTIVE_NOT_RECRUITING","city":"Frankfurt am Main","state":"Frankfurt","zip":"60438","country":"Germany","geoPoint":{"lat":50.11552,"lon":8.68417}},{"facility":"University Hospital Carl Gustav Carus","status":"RECRUITING","city":"Dresden","zip":"01307","country":"Germany","contacts":[{"name":"Thomas Hummel","role":"CONTACT","phone":"+493514582264","email":"thomas.hummel@tu-dresden.de"},{"name":"Thomas Hummel","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":51.05089,"lon":13.73832}},{"facility":"Hôpitaux Universitaires de Genève","status":"RECRUITING","city":"Genève","zip":"1211","country":"Switzerland","contacts":[{"name":"Basile Landis","role":"CONTACT","phone":"+41 223728268","email":"Basile.Landis@hcuge.ch"},{"name":"Basile Landis","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Julien Hsieh","role":"SUB_INVESTIGATOR"}],"geoPoint":{"lat":46.20222,"lon":6.14569}},{"facility":"University of Zurich and University Hospital Zurich","status":"RECRUITING","city":"Zürich","zip":"8091","country":"Switzerland","contacts":[{"name":"Michael Soyka","role":"CONTACT","phone":"+41 432538819","email":"michael.soyka@usz.ch"},{"name":"Michael Soyka","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":47.36667,"lon":8.54999}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000086382","term":"COVID-19"}],"ancestors":[{"id":"D000007239","term":"Infections"},{"id":"D000011024","term":"Pneumonia, Viral"},{"id":"D000011014","term":"Pneumonia"},{"id":"D000012141","term":"Respiratory Tract Infections"},{"id":"D000014777","term":"Virus Diseases"},{"id":"D000018352","term":"Coronavirus Infections"},{"id":"D000003333","term":"Coronaviridae Infections"},{"id":"D000030341","term":"Nidovirales Infections"},{"id":"D000012327","term":"RNA Virus Infections"},{"id":"D000008171","term":"Lung Diseases"},{"id":"D000012140","term":"Respiratory Tract Diseases"}],"browseLeaves":[{"id":"M2561","name":"COVID-19","asFound":"COVID-19","relevance":"HIGH"},{"id":"M10283","name":"Infections","relevance":"LOW"},{"id":"M6368","name":"Communicable Diseases","relevance":"LOW"},{"id":"M2570","name":"Anosmia","relevance":"LOW"},{"id":"M13904","name":"Pneumonia","relevance":"LOW"},{"id":"M13914","name":"Pneumonia, Viral","relevance":"LOW"},{"id":"M14978","name":"Respiratory Tract Infections","relevance":"LOW"},{"id":"M17522","name":"Virus Diseases","relevance":"LOW"},{"id":"M20490","name":"Coronavirus Infections","relevance":"LOW"},{"id":"M6555","name":"Coronaviridae Infections","relevance":"LOW"},{"id":"M23685","name":"Nidovirales Infections","relevance":"LOW"},{"id":"M15149","name":"RNA Virus Infections","relevance":"LOW"},{"id":"M11168","name":"Lung Diseases","relevance":"LOW"},{"id":"M14977","name":"Respiratory Tract Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC01","name":"Infections"},{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC10","name":"Nervous System Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M4107","name":"Anesthetics","relevance":"LOW"}],"browseBranches":[{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}